16 years of experience at Pfizer across various aspects of the drug development life cycle and excellent references from prior managers.
Cynthia Pussinen has more than 25 years' experience leading global organizations and high performing teams in the life sciences industry.
*/imgres?imgurl=https://www.conferenceharvester.com/uploads/harvester/photos/AOQRKQVE-Presenter-PussinenC.jpg&imgrefurl=https://bcic.bio.org/speakers/cynthia-pussinen&h=2093&w=2003&tbnid=-Ur5pLSr9jNDdM&q=Cynthia+Pussinen&tbnh=150&tbnw=144&usg=AI4_-kREVvcfgvp0srkz10PP4XcwIm5RmQ&vet=1&docid=oM1daDSqjlZGWM&hl=pt-BR&sa=X&ved=2ahUKEwjmjYbks-eIAxV3IhAIHQVuE3IQ9QF6BAgJEAQ)
*/imgres?imgurl=https://www.biopharma-reporter.com/var/wrbm_gb_food_pharma/storage/images/_aliases/small/publications/pharmaceutical-science/biopharma-reporter.com/hot-topics/cell-gene-therapies/cynthia-pussinen-ceo-of-sernova-on-how-her-career-was-written-in-the-stars/16905705-1-eng-GB/Cynthia-Pussinen-CEO-of-Sernova-on-how-her-career-was-written-in-the-stars.jpg&imgrefurl=https://www.biopharma-reporter.com/Article/2023/11/15/cynthia-pussinen-ceo-of-sernova-on-how-her-career-was-written-in-the-stars&h=86&w=99&tbnid=cs9VCzETOO0vOM&q=Cynthia+Pussinen&tbnh=71&tbnw=82&usg=AI4_-kRaaC_V8F38Cqb8ibSOPnWllTfs4w&vet=1&docid=QSOZ7ylQyAw4kM&hl=pt-BR&sa=X&ved=2ahUKEwjmjYbks-eIAxV3IhAIHQVuE3IQ9QF6BAgJEAY)
*/imgres?imgurl=https://advancedtherapiesweek.phacilitate.com/wp-content/uploads/2022/11/ATW23-Speaker-Headshots-60.png&imgrefurl=https://advancedtherapiesweek.phacilitate.com/speaker/cynthia-pussinen/&h=500&w=500&tbnid=O7DOAT9QPTn22M&q=Cynthia+Pussinen&tbnh=130&tbnw=130&usg=AI4_-kRuWo9TLFrQnddrR3C-K0REBHOj8A&vet=1&docid=xIfzMcQhUtKgRM&hl=pt-BR&sa=X&ved=2ahUKEwjmjYbks-eIAxV3IhAIHQVuE3IQ9QF6BAgJEAg)
*/imgres?imgurl=https://www.conferenceharvester.com/uploads/harvester/photos/XDQDGWMO-Presenter-PussinenC.jpg&imgrefurl=https://convention.bio.org/speakers/cynthia-pussinen&h=500&w=500&tbnid=1Yub6PNIW9nn8M&q=Cynthia+Pussinen&tbnh=130&tbnw=130&usg=AI4_-kQ0B5fujY_9_GwkWGorX6r1OMSTQw&vet=1&docid=WrbcqU1a8a076M&hl=pt-BR&sa=X&ved=2ahUKEwjmjYbks-eIAxV3IhAIHQVuE3IQ9QF6BAgJEAo)
*/imgres?imgurl=https://pbs.twimg.com/media/EvEpQmrWgAcSKkY.jpg&imgrefurl=https://twitter.com/jeffmarrazzo/status/1364918103445012483&h=512&w=1024&tbnid=yvTs76YRyE1JRM&q=Cynthia+Pussinen&tbnh=75&tbnw=150&usg=AI4_-kSsR8E4MZkMQMxUOhrB3Tqxkmy4qw&vet=1&docid=OIBaWGv7RSRNBM&hl=pt-BR&sa=X&ved=2ahUKEwjmjYbks-eIAxV3IhAIHQVuE3IQ9QF6BAgJEAw)
26 de fev. de 2024 · Cynthia Pussinen's expertise spans the drug development continuum from research through commercialization. For the past 30 years, ...
15 de nov. de 2023 · I recently joined Sernova as the chief executive officer. Sernova is a clinical stage biotech company focused on the advanced therapeutics space ...
14 de set. de 2023 · Cynthia Pussinen is an extremely accomplished and respected scientist and global pharmaceutical executive with an impressive track record of bringing ...
5 de set. de 2023 · Sernova Corp., a clinical-stage company and leader in cell therapeutics, announced that its Board of Directors has appointed Cynthia Pussinen as ...
Ms. Pussinen's expertise spans the drug development continuum from research through commercialization. She has led the development, licensure, ...
16 de nov. de 2023 · Our CEO, Cynthia Pussinen, was recently featured in a BioPharma-Reporter Women in Science article highlighting her impressive career ...
Company status: Active. Correspondence address: Stafford House, Blackbrook Park Ave, Taunton, United Kingdom, TA1 2PX. Role Resigned: Director.